WHO launches new global influenza strategy    
submitted by kickingbird at Mar, 12, 2019 from WHO
WHO released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza. The goal of the strategy is to prevent seasonal influenza, control the spread ...

OIE: Equine Influenza, Niger    
submitted by kickingbird at 5 hours ago from OIE
Information received on 14/07/2019 from Dr Issiako Abdou, Directeur général des Services véterinaires, Direction de la Santé Animale, Ministère de l'Agriculture et de l'Elevage, Niamey, Niger Summary Report ...

OIE: Highly pathogenic avian influenza, South Africa    
submitted by kickingbird at 4 days ago from OIE
Information received on 11/07/2019 from Dr Bothle Michael Modisane, Chief Director , Department of Agriculture, Forestry and Fisheries, Animal Production and Health, PRETORIA, South Africa ...

OIE: Low pathogenic avian influenza (poultry), Chinese Taipei    
submitted by kickingbird at 7 days ago from OIE
Information received on 08/07/2019 from Dr Wen-Jane Tu, Chief Veterinary Officer, Deputy Director General, Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, ...

OIE: Equine influenza, Sudan    
submitted by kickingbird at 9 days ago from OIE
Information received on 05/07/2019 from Dr Ahmed Shiekh Eldin, Undersecretary, Chief Veterinary Officer, Veterinary Services , Ministry of Animal Resources, Khartoum, Sudan Summary Report type Immediate ...

Kingstad-Bakke BA, et al. Effective mosaic-based nanovaccines against avian influenza in poultry. Vaccine. 2019 Jul 9.  Abstract  
submitted by kickingbird at 22 hours ago from Vaccine. 2019 Jul 9
Avian influenza virus (AIV) is an extraordinarily diverse pathogen that causes significant morbidity in domesticated poultry populations and threatens human life with looming pandemic potential. Controlling ...

Rim A, et al. Viral interference between H9N2-low pathogenic avian influenza virus and avian infectious bronchitis virus vaccine strain H120 in vivo. Comp Immunol Microbiol Infect Dis. 2019 Aug;65:219.  Abstract  
submitted by kickingbird at 22 hours ago from Comp Immunol Microbiol Infect Dis. 2019 Aug;65:219
The interaction between a low pathogenic avian influenza virus (A/CK/TUN/145/2012), a H9N2 Tunisian isolate, and a vaccine strain (H120) of avian infectious bronchitis, administered simultaneously or sequentially ...

Li M, et al. A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site a from fifth wave H7N9-infected humans. Antiviral Res. 2019 Jul 9:104556..  Abstract  
submitted by kickingbird at 22 hours ago from Antiviral Res. 2019 Jul 9:104556.
Subtype H7 avian influenza viruses have been found to be associated with human infection and represent a risk for global public health. In 2013, the emergence of H7N9 virus in human beings and persistent ...

Collins JP, et al. Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011~2015. Clin Infect Dis. 2019 Jul 11..  Abstract  
submitted by kickingbird at 22 hours ago from Clin Infect Dis. 2019 Jul 11.
BACKGROUND: Hospitalized immunocompromised (IC) adults with influenza may have worse outcomes than hospitalized non-immunocompromised adults.METHODS: We identified adults (≥18 years) hospitalized with ...

Abood RN, et al. IL-22-binding protein exacerbates influenza, bacterial super-infection. Mucosal Immunol. 2019 Jul 11..  Abstract  
submitted by kickingbird at 22 hours ago from Mucosal Immunol. 2019 Jul 11.
Secondary bacterial pneumonia is a significant complication of severe influenza infection and Staphylococcus aureus and Streptococcus pneumoniae are the primary pathogens of interest. IL-22 promotes S. ...